CUSIP: 88165U109
Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
6,199,303
-
Share change
-
-98,777
-
Total reported value
-
$11,493,000
-
Price per share
-
$1.87
-
Number of holders
-
29
-
Value change
-
-$312,466
-
Number of buys
-
11
-
Number of sells
-
10
Quarterly Holders Quick Answers
What is CUSIP 88165U109?
CUSIP 88165U109 identifies TLOG - TETRALOGIC PHARMACEUTICALS C - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2015
-
Previous quarter:
Q2 2015
Recent filing periods for CUSIP 88165U109:
Institutional Holders of TETRALOGIC PHARMACEUTICALS C - COM (TLOG) as of Q3 2015
As of 30 Sep 2015,
TETRALOGIC PHARMACEUTICALS C - COM (TLOG) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,199,303 shares.
The largest 10 holders included
Clarus Ventures, LLC, First Eagle Investment Management, LLC, First Washington CORP, VANGUARD GROUP INC, Bank of New York Mellon Corp, WELLINGTON MANAGEMENT GROUP LLP, Alyeska Investment Group, L.P., GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, and HighTower Advisors, LLC.
This page lists
29
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.